Perio Aid® Intensive Care

Perio Aid® Intensive Care, an antiseptic containing 0.12% CHX + 0.05% CPC, is specially formulated to achieve maximum active control of the bacteria that cause periodontal and peri-implant diseases.

Its formula contains:

Intended for short periods of 2 to 4 weeks in:

  • The use of oral anti-septics for periodontal and/or peri-implant disease is essential to ensure the elimination and control of the pathogens that these diseases.
  • Pre- and post-surgical disinfection: tooth extractions, periodontal surgery, implant surgery, etc.
  • Immunocompromised and/or medically compromised patients
  • Oral complications from cancer treatment
  • Gingival overgrowth
  • Patients at high risk for caries, root caries, polycaries
  • Aphthous ulcers

  • The use of oral anti-septics for periodontal and/or peri-implant disease is essential to ensure the elimination and control of the pathogens that these diseases.
  • Prevents infection before and after any intervention in the oral cavity

How to use:

Rinse for 30 seconds with 15 ml, 2 times per day (morning and night), after brushing.
In oral irrigators, dilute with water in a 1:1 or 2:1 ratio (water:mouthwash).
Do not swallow.

It is not advisable to rinse with water or eat food immediately after using Perio·Aid®Intensive Care mouthwash, as this may enhance its bitter flavour.

  • Fights bacterial plaque that causes periodontal and peri-implant disease on a daily basis.
  • Can be applied topically to affected areas.

*Its formula only contains 0.12% CHX digluconate

How to use:

Use as regular toothpaste, applying a small amount of gel to your toothbrush. Brush affected areas carefully at least 2 times per day.

Can be applied topically to affected areas.

Do not swallow.

  • Its nozzle allows it to access hard-to-reach areas of the oral cavity
  • For local application that is suitable for all types of people.

How to Use:

Spray 2-3 times aiming the nozzle directly on the indicated area, 2-3 times per day.
Do not swallow.


It is advisable not to rinse with water or intake any food or drink immediately after using Perio•Aid® Intensive Care Spray.

The advantages of combining 0.12% CHX + 0.05% CPC in Perio·Aid® Intensive Care are endorsed by different independent studies:

  • It is an effective anti-plaque and anti-inflammatory agent with reduced side effects (Quirynen et al. 2001)1
  • Mouthrinses with 0.12% CHX were effective in reducing salivary microbiota, but showed significant differences in their activity depending on their composition. (Herrera et al. 2001)2
  • The complete composition of a mouthrinse has a significant impact on its effectiveness, no matter the active substance (Herrera et al. 2001)2
  • Presence of an active component in a formulation, such as CHX, does not guarantee that the product will be effective (Herrera et al. 2001)2
  • Significant differences were observed between different mouthwash formulations containing 0.12% CHX. The mouthrinse containing CHX + CPC showed the greatest antimicrobial activity. (Herrera et al. 2001)3
  • The results of this in vitro study showed clear differences in the antimicrobial activity of different 0.12% CHX products, pointing out that the complete composition of these products significantly influences their antibacterial capacity (Herrera et al. 2001)4

Significant differences were detected in the activity of the 0.12% CHX products, both when tested in vivo and in vitro. The formulation containing alcohol was more active than those that did not contain alcohol, except for the formulation with CHX + CPC (Perio•Aid® Intensive Care), in which the addition of CPC not only compensated for its lack of alcohol, but also boosted its antimicrobial effect (Herrera et al. 2003)5.

  • Rinsing with an alcohol-free CHX mouthrinse containing 0.05% CPC (Perio·Aid) did not show differences compared to 0.2% CHX mouthrinses containing alcohol (Van Strydonck et al. 2005)6
  • The use of the test product (Perio•Aid® Intensive Care) may improve clinical parameters (better control over plaque index, gingival index and infections caused by C. albicans) in patients undergoing radiation therapy for head and neck cancer (Lanzós et al. 2010)7
  • The use of the 0.12% CHX + 0.05% CPC mouthwash may improve microbial parameters in patients with head and neck cancer (Lanzós et al. 2011)8
  • The results suggest antifungal activity of mouthwashes containing CHX or CPC or a combination of both against C. tropicales and C. krusei. Rinsing with mouthwashes that possess this antifungal activity would trigger a rapid reduction in the candida population in patients with fungal infections (Fathilah et al. 2012)9.